Portfolio company
Reverie Labs
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops machine learning software to design small-molecule kinase inhibitors for pharmaceutical firms and research institutions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Harmonic Discovery
The company develops a machine learning platform to design multi-targeted kinase therapeutics for pharmaceutical firms and healthcare providers treating cancer and autoimmune diseases.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Molecular Glue Labs
This company develops artificial intelligence software and infrastructure to design small-molecule drugs that reprogram protein networks to treat previously untreatable diseases.
Revanta
Revanta develops an artificial intelligence platform for drug design to support biotechnology companies.
DreamFold
This company develops generative AI models for protein design to discover new therapeutic drugs for pharmaceutical researchers and clinicians.
Chai Discovery
This company develops artificial intelligence models to predict and design molecular structures and protein binders for pharmaceutical and life sciences researchers.
Valence Discovery
This company provides a machine learning platform for molecular design and lead optimisation to pharmaceutical and biotechnology firms.
DreamFold AI
This company develops generative artificial intelligence models for protein design to discover medicines for pharmaceutical and biotechnology researchers.
